Clinical Trial: Predicting Vital Pulp Treatment Outcomes in Symptomatic Pulpits Using Metabolic Biomarker: A Controlled Clinical Trial

U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT07452614) titled 'Predicting Vital Pulp Treatment Outcomes in Symptomatic Pulpits Using Metabolic Biomarker: A Controlled Clinical Trial' on Feb. 28.

Brief Summary: This prospective controlled clinical trial investigates whether metabolic biomarkers measured in pulpal blood at the time of carious pulp exposure can predict the 12-month outcomes of vital pulp treatment in symptomatic permanent teeth. Eligible patients aged 16-50 years presenting with deep carious pulp exposure will undergo vital pulp therapy (partial pulpotomy or full pulpotomy). Pulpal blood samples will be collected at the time of exposure and analyzed using High-Performance Liquid C...